Myriad Genetics Inc (NASDAQ:MYGN)

35.40
Delayed Data
As of May 18
 +0.44 / +1.26%
Today’s Change
19.75
Today|||52-Week Range
41.57
+3.07%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Marsh Richard M
Executive Vice President & General Counsel
Sale1/18/201840,000$38.25$1.5M-6.82%
Marsh Richard M
Executive Vice President & General Counsel
Sale1/22/201837,654$40.25$1.5M-11.23%
Marsh Richard M
Executive Vice President & General Counsel
Buy1/18/201840,000$30.12$1.2M-6.82%
King Gary A /myriad/
Executive Vice President
Sale1/22/201830,000$39.77$1.2M-11.23%
Marsh Richard M
Executive Vice President & General Counsel
Buy1/22/201837,654$30.12$1.1M-11.23%
Capone Mark C
President & Chief Executive Officer
Sale9/30/201719,367$36.18$700.7K-3.75%
King Gary A /myriad/
Executive Vice President
Buy1/22/201830,000$19.47$584.1K-11.23%
Marsh Richard M
Executive Vice President & General Counsel
Sale1/12/201813,759$36.25$498.8K-1.80%
Capone Mark C
President & Chief Executive Officer
Sale9/17/201711,671$33.05$385.7K+7.11%
Capone Mark C
President & Chief Executive Officer
Sale9/30/20179,238$36.18$334.2K-3.75%
Page of 7